Status:

UNKNOWN

MR-simulation in Radiotherapy for Prostate Cancer

Lead Sponsor:

Guy's and St Thomas' NHS Foundation Trust

Conditions:

Cancer of the PROSTATE

Eligibility:

MALE

18+ years

Phase:

NA

Brief Summary

To assess the feasibility of acquiring an MR scan in the radiotherapy treatment position as part of the patient's radiotherapy pathway and incorporating the data into our radiotherapy planning systems...

Detailed Description

Conventional radiotherapy treatment planning uses computed tomography (CT) scans to provide an accurate 3-D picture of the local anatomy. This helps the planners to maximise the radiation dose deliver...

Eligibility Criteria

Inclusion

  • Written, voluntary, informed consent
  • Age ≥ 18
  • ECOG Performance Status ≤ 2
  • Life expectancy \> 12 months
  • Histologically proven carcinoma of the prostate
  • Radical radiotherapy +/- hormones indicated as the primary treatment modality
  • Staging diagnostic MRI of the prostate need to be available for comparison.
  • Adequate organ function and absence of other major concurrent illness, allowing

Exclusion

  • Inability to provide informed consent
  • Impaired renal function (serum creatinine of \> 200)
  • Severely impaired liver function
  • Patients with allergies or contra-indications to the gadolinium contrast agent that may be used in the study
  • Severe claustrophobia or inability to tolerate MRI scans
  • General contra-indications to MRI including cardiac pacemakers and defibrillators, metallic prosthetic devices, aneurysm clips and metal fragments in the eyes, as defined in MRI safety departmental protocols
  • Serious inter-current conditions or other non-malignant illnesses that are uncontrolled or whose control may be affected by participation in this study
  • Any patient who has urinary or faecal incontinence
  • Status greater than or equal to 3

Key Trial Info

Start Date :

March 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2023

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT03238170

Start Date

March 1 2017

End Date

June 1 2023

Last Update

March 18 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Guy's and St. Thomas' NHS Foundation Trust

London, United Kingdom, SE19RT